ROCHESTER, Minn. – Leaders from both the Mayo Clinic and city of Rochester met with officials from an overseas company on Tuesday.
Cardio3 BioSciences, which is based in Belgian, is in Rochester for three days. The group, which has worked with Mayo before, is hoping that Rochester could be the home for one of their facilities in the future. However, that’s not the only topic on the table with leaders, they are also talking about an upcoming clinical trial that involves the heart. “What we do is take cells from a patient and we reprogram those cells…those cells have the ability to come and repair the heart,” President and CEO of Cardio3 BioSciences Dr. Christian Homsy said.
That trial could begin this year.